Quintiles and Kaiser Permanente’s Southern California Permanente Medical Group (SCPMG) have entered an agreement aimed at accelerating the development of new and more effective medicines. SCPMG will join three of Quintiles’ global sites and both companies will work together to enhance the productivity and quality of clinical research offered at the SCPMG site. According to the companies, biopharmaceutical companies sponsoring trials will benefit from greater collaboration between clinicians a...